Pioneering wearable relief.
Quell was created by a group of scientists and technologists at NeuroMetrix, Inc. NURO (NASDAQ) who have spent over 15 years developing patented diagnostic technology and innovative wearable therapy solutions for people suffering from chronic pain and sleep disorders. Until now these solutions have been reserved for prescription through a healthcare professional. NeuroMetrix is committed to empowering people to regain a high quality of life. By working closely with clinicians and combining novel neurotechnology plus innovative design, NeuroMetrix brings high-tech, high quality solutions to your home.
We believe that life shouldn’t be defined by a condition. We believe that no one should have to settle for crippling side effects and we imagine a future where therapies are accessible, available and usable for anyone who needs it.
About our management team.
SHAI N. GOZANI, M.D., PH.D.
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Shai N. Gozani, M.D., Ph.D. founded NeuroMetrix, Inc. in 1996 as a spin-off from the Massachusetts Institute of Technology. NeuroMetrix is a publicly traded (Nasdaq:NURO) medical technology company that develops innovative wearable technology and point-of-care neurodiagnostic devices.
The Company’s products are used all over the world to help physicians and patients better manage chronic pain, neurological diseases, and sleep disorders. Over 2.5 million patients have benefited from the Company’s technology over the past 19 years. Dr. Gozani has led the Company from a venture capital backed start-up, through an initial public offering on Nasdaq, through development of a successful diagnostics business, and presently into the wearable technology sector. Dr. Gozani currently serves as Chairman of the board of directors and as President and Chief Executive Officer. Dr. Gozani has published over 30 peer-reviewed scientific articles and has been awarded 25 US and international patents.
Dr. Gozani holds a B.A. degree in Computer Science, an M.S. degree in Electrical Engineering & Computer Science (Biomedical Engineering Focus) and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.
THOMAS T. HIGGINS
SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
Mr. Higgins contributes a broad set of financial management and operations skills from his CFO experience with publicly traded companies in multiple industries such as life sciences, specialty chemicals and financial services. He has extensive international experience with a particular emphasis on Japan, Southeast Asia and the Middle East.
Mr. Higgins started his career with PricewaterhouseCoopers and holds a B.B.A. with honors from Boston University.
SENIOR VICE PRESIDENT AND GENERAL MANAGER, CONSUMER HEALTH
Mr. McGillin brings over 20 years of experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
At Philips Mr. McGillin was responsible for building the global oral care business of Sonicare becoming the #1 brand in the nearly $1 billion dollar US power toothbrush market. During his career at Philips and Johnson & Johnson, he launched over 50 new products and product upgrades and managed businesses across markets including diagnostic imaging, healthcare informatics, medical devices, dental and consumer technology.
Mr. McGillin holds an M.B.A. from Fordham University and a B.S. from Northeastern University.
MICHAEL J. MACDONALD
SENIOR VICE PRESIDENT OF COMMERCIAL OPERATIONS
Mr. MacDonald joined the company in September 2000 and has held several marketing and sales positions including Vice President of Marketing, Vice President of Healthcare Economics, Director of Marketing and Region Sales Manager.
Mr. MacDonald previously held various marketing positions at Smith & Nephew Endoscopy, a world leader in minimally invasive surgical devices and at Deknatel, Inc., a company specializing in the development of products for cardiovascular and other specialty surgery markets.
Mr. MacDonald holds a B.S. degree in Business Administration from Northeastern University.
XUAN KONG, PH.D.
SENIOR VICE PRESIDENT OF RESEARCH AND INTELLECTUAL PROPERTY
Dr. Kong joined the company in 1999. In his role of SVP Research and Intellectual Property, he provides leadership for the Company’s internal and external basic research functions. He manages the Company’s intellectual property portfolio and is responsible for evaluation and licensing of outside intellectual property for the development of diabetic neuropathy related products.
Prior to joining the company, Dr. Kong was a tenured associate professor in the Department of Electrical Engineering at Northern Illinois University (Dekalb, IL). As a principal investigator, he successfully led many federally and industrially funded projects in signal processing research and bio- electric signal analysis applications. He has published numerous papers in leading signal processing, biomedical engineering, and clinical neurophysiology journals.
Dr. Kong received his Ph.D. from The Johns Hopkins University and M.B.A. from Boston University. He is certified as professional risk manager by PRMIA. He is a senior member of IEEE and a member of Eta Kappa Nu and Beta Gamma Sigma.